Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 168INDUSTRY 42NIH 4OTHER_GOV 3UNKNOWN 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Lymphoid 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 24Stomach Neoplasms 21Rectal Neoplasms 15Colorectal Neoplasms 12Esophageal Squamous Cell Carcinoma 6Carcinoma, Hepatocellular 5Colonic Neoplasms 3Radiation Injuries 2Urinary Bladder Neoplasms 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Locally Advanced Pancreatic Cancer 1Liver Neoplasms 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1HER2-positive 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Extrapancreatic Neuroendocrine Tumor 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Anus Neoplasms 1Advanced Pancreatic Cancer 1Advanced Colorectal Cancer 1Adenocarcinoma 1

Interventions

pegylated granulocyte colony-stimulating factor 1Platinum 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Recurrence × Gastrointestinal × Clear all
NCT03731442 2018-12-12

Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients

ChineseAMS

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Esophageal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡